Golcadomide

戈可度胺

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameGolcadomide
Drug Alias NameCC-99282BMS-986369A/I CELMoD
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionDNA-binding protein Ikaros degradersZinc finger protein Aiolos degraders
TargetsDNA-binding protein IkarosZinc finger protein Aiolos
Therapy Area/IndicationsPrimary mediastinal B cell lymphomaHepatic InsufficiencySkin Neoplasms +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[43] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesBristol Myers Squibb SrlcompanyBristol-Myers Squibb (China) Investment Co LtdFondazione Italiana Linfomi Onlus +[9] 
Inactive CompaniesUniversity Of Pittsburgh
Active IndicationsPrimary mediastinal B cell lymphomaHepatic InsufficiencySkin Neoplasms +[10] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A